Articles By Anuja Singh

Blackstone’s $400M Bet on Teva–Sanofi Gut Drug Signals a Major Shift in the IBD…

Blackstone has invested $400 million into Teva and Sanofi’s experimental ulcerative colitis (UC) and Crohn’s disease therapy, marking one of…

ByByAnuja Singh Mar 5, 2026
Has China Now Overtaken the US at the Heart of Biotech Innovation?

Recent data from JPM2026 shows that China has surpassed the United States in key biotech activity measures—topping the…

ByByAnuja Singh Mar 4, 2026
Is Hong Kong Becoming Asia’s AI–Biopharma Hub?

Hong Kong is emerging as a key AI‑biopharma hub, with recent deals like Earendil Labs’ partnership with Sanofi…

ByByAnuja Singh Mar 4, 2026
Is Insilico’s AI Drug Engine “Einstein” Turning China into the Global AI–Pharma Hub?

Insilico Medicine’s AI‑driven drug discovery platform, Pharma.AI “Einstein,” is scaling fast in China, with a major expansion of…

ByByAnuja Singh Mar 4, 2026
Biotech Licensing Soars to $137B in 2025 – China Now Leads the Licensing Race

The global biotech licensing market hit a record $137 billion in 2025, and 2026 is on track to…

ByByAnuja Singh Mar 4, 2026
China Dominates 70% of Global AI Drug Patents: ADC/Bispecifics Surge or Innovation Bubble?

China Leads 70% of Global AI Drug Patents: Simple Strategic Snapshot China now holds 70% of the world’s…

ByByAnuja Singh Mar 4, 2026
Image Not Found
Blackstone’s $400M Bet on Teva–Sanofi Gut Drug Signals a Major Shift in the IBD…

Blackstone has invested $400 million into Teva and Sanofi’s experimental ulcerative colitis (UC) and Crohn’s disease therapy, marking one of…

ByByAnuja Singh Mar 5, 2026
Has China Now Overtaken the US at the Heart of Biotech Innovation?

Recent data from JPM2026 shows that China has surpassed the United States in key biotech activity measures—topping the…

ByByAnuja Singh Mar 4, 2026
Is Hong Kong Becoming Asia’s AI–Biopharma Hub?

Hong Kong is emerging as a key AI‑biopharma hub, with recent deals like Earendil Labs’ partnership with Sanofi…

ByByAnuja Singh Mar 4, 2026
Is Insilico’s AI Drug Engine “Einstein” Turning China into the Global AI–Pharma Hub?

Insilico Medicine’s AI‑driven drug discovery platform, Pharma.AI “Einstein,” is scaling fast in China, with a major expansion of…

ByByAnuja Singh Mar 4, 2026
Biotech Licensing Soars to $137B in 2025 – China Now Leads the Licensing Race

The global biotech licensing market hit a record $137 billion in 2025, and 2026 is on track to…

ByByAnuja Singh Mar 4, 2026
China Dominates 70% of Global AI Drug Patents: ADC/Bispecifics Surge or Innovation Bubble?

China Leads 70% of Global AI Drug Patents: Simple Strategic Snapshot China now holds 70% of the world’s…

ByByAnuja Singh Mar 4, 2026
Scroll to Top